Skip to main content

Table 5 Response to treatment according to anatomic classification of autoimmune uveitis

From: Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center

Treatment

Remission

Improvement

Worsening

( n , %)

(45 pts, 43.3%)

(28 pts, 26.9%)

(31 pts, 29.8%)

Anterior

Intermediate

Posterior

Panuveitis

Anterior

Intermediate

Posterior

Panuveitis

 

Corticosteroids (5, 4.8)

2

 

1

 

1

   

1

Corticosteroids + Azathioprine (36, 34.6)

9

1

  

7

1

2

1

15

Corticosteroids + Cyclosporin-A (35, 34.6)

1

1

8

 

2

1

8

1

12

Corticosteroids + Cyclophosphamide (8, 7.6)

  

3

1

  

1

1

2

Corticosteroids + Methotrexate (2, 1.9)

1

 

1

     

1

Corticosteroids + combined immuno-suppressive therapy (8, 7.6)

1

1

2

2

  

1

1

 

Anti-tumor necrosis factor-α (7, 6.7)

1

 

3

3

    

0

Anti-vascular endothe-lial growth factor (3, 2.9)

  

2

1

    

0